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Summary: The incorporation of [35S]sulfate into total and specific glycosaminoglycans of the liver of rats injured
acutely by a singie intraperitoneal dose of either jD-galactosamine (700 and 350 mg/kg body weight, respectively) or
thioacetamide (100 mg/kg body weight) was studied in vivo and in liver slices. Regardless of the chemical nature of
the hepatotoxic agent and its mechanism of action the incorporation of isotope in vivo is changed biphasically:
a rapidly occurring and strong Inhibition is followed by pronounced elevation in later stages of injury. In contrast
to the dose-dependent Inhibition of heparan sulfate formation the production of chondroitin sulfate and dermatan
sulfate is only slightly and for a rather short period of time diminished. The synthesis of the latter glycosamino-
glycans is stimulated 3 to 4 fold 8 to 24 h after onset of liver damage, fhat of heparan sulfate about 2 fold. Impaired
synthesis of heparan sulfate occurs before the elevation of the activities of aspartate aminotransferase, alanine
aminotransferase, and leucine arylamidase in serum. The specific radioactivity of 3'-phosphoadenosine-5'-phospho-
sulfate remains nearly constant in galactosamine-damaged livers. Similar time-dependent changes of [3S S]sulfate
incorporation into heparan sulfate, chondroitin sulfate and dermatan sulfate were measured in slices from livers
injured in vivo for various times with -D-galactosamine or thioacetamide. Neither serum from normal nor galactos-
aniine-treated rats influences the total amount and the pattern of glycosaminoglycans synthesized in normal or
injured liver slices. Hepatic glycosaminoglycan formation of 3.5 and 33 months old rats responds quantitatively and
qualitatively in a simüar way to £>-galactosamine; 50% Inhibition is reached with about 80 mg/kg of the hepato-
toxin. The Inhibition of heparan sulfate synthesis in early injured livers could not be reversed by addition of p-nitro-
phenyl-/3-Z)-xylopyranoside to the medium (final concentration l mmol/1), but in rats treated with diethyldithio-
carbamate or the flavonoid (+)-cianidanol-3, prior to injection of Z)-galactosamine, a partial restoration of the
diminished synthesis of total glycosaminoglycans and of heparan sulfate is achieved.
Die Sequenz der Änderungen der Biosynthese sulfatierter Glykosaminoglykane bei akuten, experimentellen
Lebererkrankungen
Zusammenfassung: Der Einbau von [3*S]Sulfat in die gesamten und spezifischen Glykosaminoglykane der Leber von
Ratten, die akut geschädigt wurden durch eine intraperitoneale Einzelinjektion von entweder Z)-Galaktosamin
(700 mg/kg oder 350 mg/kg Körpergewicht) oder Thioacetamid (100 mg/kg), wurde in vivo und in Leberschnitten
untersucht. Ungeachtet der chemischen Natur der hepatotoxischen Substanz und ihres Wirkungsmechanismus kommt
es zu einer biphasischen Änderung des Isotopeinbaues: eine unmittelbar auftretende und starke Hemmung wird
gefolgt von einer ausgeprägten Erhöhung in späteren Stadien der Schädigung. Im Gegensatz zu der dosisabhängigen
Hemmung der Heparansulfatbildung ist die Produktion von Chondroitinsulfat und Dermatansulfat nur geringfügig
und während eines kürzeren Zeitraums vermindert.
Die Synthese der letztgenannten Glykosaminoglykane ist 3- bis 4-fach stimuliert 8 bis 24 h nach Beginn der Schädi-
gung, die von Heparansulfat ungefähr 2-fach. Die beeinträchtigte Heparansulfatsynthese geht der Erhöhung der
Aktivitäten von Alaninaminotransferase, Aspartataminotransferase und Leucinarylamidase im Serum zeitlich voraus.
Die spezifische Radioaktivität von 3'-Phosphoadenosin-5'^hosphosulfat bleibt nahezu konstant in Galaktosamin-
geschädigiten Lebern. Ähnliche zeitabhängige Änderungen der [3S SJSulfat Inkorporation in Heparansulfat, Chondro-
itinsulfat und Dermatansulfat wurden in Schnitten von Lebern gemessen, die für verschieden lange Zeiten in vivo mit
D-Galaktosamin bzw. Thioacetamid vorgeschädigt wurden. Weder Serum von normalen noch Galaktosamin-behandelten
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Ratten beeinflußt die Menge und das Muster der in vitro von normalen und geschädigten Leberschnitten synthetisierten
Glykosaminoglykane. Die Glykosaminoglykanbüdung in den Lebern von 2,5 und 33 Monate alten Ratten wird in
quantitativ und qualitativ gleicher Weise von D-Galaktosamin beeinflußt; 50% Hemmung wird erreicht bei einer Dosis
der hepatotoxischen Substanz von ungefähr 80 mg/kg Körpergewicht. Die Hemmung der Heparansulfatsyrithese in
frühgeschädigten Lebern konnte nicht revertiert werden durch Zugabe von p-Nitrophenyl-|3-£-xylopyranosid zum
Medium (Endkonzentration l mmol/1) aber in Ratten, die vor der Galaktosamininjektion mit Diethyldithiocarbamat
oder dem Flavonoid (-i-)Cianidanol-3 behandelt wurden, ließ sich eine partielle Wiederherstellung der verminderten
Synthese der gesamten Glykosaminoglykane und des Heparansulfates erreichen.
Introduction
The understanding of the metabolism of proteoglycans
in liver is of great importance both from a physiological
and pathobiochemical point of view. Normally the con-
centration of glycosaminoglycans, i.e. the polysaccharide
side chains of proteoglycans, in liver is low (1—4), but
they are metabolized at a rather high rate (5, 6). Heparan
sulfate, the preponderant type of glycosaminoglycan in
liver (7,8) occurs predominantly in the microenviron-
ment of the cell, i.e. the external surface of the hepato-
cyte (6,9-12) and piay there control the exchange of
metabolites, ions, fluids, and wateir, exert some effects
on hepatocellular proliferation and may regulate the
accessibility of cell surface receptors (13—15). The
physiological significance of the galactosamine con-
taining sulfated glycosaminoglycans (chondroitin sulfate,
dermatan sulfate) in liver is not known.
The concentration of heparan sulfate and also of chon-
droitin sulfate and dermatan sulfate in the distal portion
of the intercellular space increases dramatically in long-
term damaged livers, leading to the fibrotic transition of
the tissue (for recent reviews see (16—18)). As discussed
previously (17,18) neither the cellular nor molecular
pathobiochemical mechanism responsible for the accu-
mulation of liver proteoglycans (and also of collagens)
are well understood. The present work was undertaken
to elucidate some principle features of glycosamino-
glycan metabolism in acutely damaged livers which might
be meaningful both for the pathobiochemistry of hepato-
cellular damage and for the pathogenesis of liver fibrosis,
which develops if the hepatotoxic agent is applied con-
tinuously at a certain dose. Therefore the studies were
performed in the early phases of two independent, well
defined experimental models of liver disease, i.e. D-
galactosamine hepatitis (19-21) and thioacetamide-
induced liver injury (22, 23), which both result ulti-
mately in liver fibrosis and cirrhosis (24-27).
carrier-free sodium [3S S J sulfate, 3^phosphoadenq:$ine-5'-
phosphosuifate (tetrasodiiurn salt, 3'-[35S]), unlabeled glycos-
aminoglycans, chondroitin AClyase (EC 4.2.2.5), chondroitin
ABC lyase (EC 4.2.2.4), papain (EC 3.4.22.2), harmol - 'HC1, and
thin-layer chromatogräphy plates (CEL 300-25). Puromycin-
dihydrochloride was purchased from Boehringer, Mannheim,
FRG; dimethylsulfoxide (analytical grade) was irom E. Merck
AG., Darmstadt, FRG; diethyldithiocarbamic acid (sodium salt,
lot. 79 C-0125) andp-nit pphenyl·J(^.D-xylopy anoside (lot. 88O
0487) were from Sigma ChemicalComp., St. Louis, USA;
L-(4,5-3H]leucine was from New England Nüclear, Boston,
USA, and pentobarbital (Neinbutal (pharrn.)) from Serva, H'ejdel-
berg, FRG. (+)Cianidariol-3 (lot, N 26473/,4<,5,7-tetrahydroxy-
flavanol) was kindly provided by Zyma GmfcH, Munich, FRG.
Treatment ofrats
Male Sprague-Dawley rats (Lippische Versuchstieranstalt, Exter-
tal, FRG) weighing 200-300 g had free access to a Standard rat
diet and water throughout the experimental period. Age-related
studies were performed with 3.5 (bödy weight about 350 g) and
33 months old (body weight about 600 g) male Han<: Wistar rats
(Zentralinstitut für Versuchstiere, Hannover, FRG); Betweerc
8:00 and 11:00 a.m. they were injeeted intraperitoneally either
with jD-galactosamine or thioacetamide both freshly dissoived
in 0.154 mol/l of NaCl (saune). The precise doses are given in the
legends of the appropriate figures and tables. Control rats received
a similar volume of NaCl alone.
If the synthesis of liver glycpsaminpglycans was studied in vivo
the rats received, at certain times after application of the toxic
agent and 30 min prior decapitation, 3.7 MBq of [3SS)sulfate
intraperitoneally. The liver was quickly excised, minced, washed
in ice-cold phosphate-buffered saline and processed for the
Isolation of labeled glycosämirioglycans äs described below.
If the liver was used for preparation of slices the animals were
anaesthetized by intraperitoneal injection of pentobarbital (54 mg/
kg body weight). The livers were perfused in situ for 3 min with
ice-cold phosphate-buffered saline at a flow rate of 30 ml/min.
Preparation and incubation of liver slices
In principle the procedure described in detäil previously was
applied (5). In brief, slices of 0.5 mm thickness (about 100 mg
wet weight) were prepared manually and ineubaled for 3 h at
37 °C and 90 oscillations/min in 3 ml ofDulbeccos modifieation
of Eagles medium (pH 7.4) under C^-COi mixture, volume frac-
tion 0.95/0.05. 0.93 MBq (50, ) öf [35S]sulfate were added at
the beginning of the incubation. At the end, the slices were
washed briefly in ice-cold buffered saline and transfered immedi-
ately into about 10 ml of cold acetone.
Materials and Methods
The commercial sources and specifications of the following
materials and reagents have been described previously (4, 28):
£>-galactosamine hydrochloride, thioacetamide, phosphate-
buffered saline, Dulbeccos modifieation of Eagles medium,
Measurement ofthe incorporation of(35S]sulfaie into total
and specific glycosaminoglycans
The livers labeled in vivo and the slices labeled in vitro with
[35S)sulfate were repeatedly washed (defatted) in coldaeetone,
chloroforni-methanol (200 ml) and ethanol-ether (300 ml>after
which the material was dried for 24 h at 60 °C. The delipidized
slices Were hofnpgenized in 5 ml of buffered papain (29) from
which an aliquot was taken for the determination of proteih with
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t he Lowry proceduie, using bovine serum albumin s a Standard
(30). In vivo labeled, defatted and dried tissue was weighed prior
to Suspension in buffered papain. The tissue was exhaustively
proteolysed with papain (5). From the proteolysed, trichloro-
acetic acid-soluble, and dialysed material [3S S Habeled giycos-
aminoglycans togcther with added unlabeled glycosamino-
glycans s carrier were precipitated with cetylpyridinium
Chloride s described previously (5). The radioactivity of the
isolated glycosaminoglycans was measured and refered to defatted
liver dry weight (in vivo experiments) and protein (in vitro).
For differentiation of specific types, the unfractionated glycos-
aminoglycans were subjected to enzymatic degradation with
chondroitin AC and ABC lyases to yield the incorporation of
|3SSJsulfate into chondroitin 4,6-sulfate and dermatan sulfate,
respectiveiy. They were also degraded with nitrous acid to
measure the heparan |3SS]sulfate (5). Synthesis of specific
glycosaminoglycans is expressed either in absolute terms (Bq/g
protein), or relatively s a fraction of total glycosaminogiycan
synthesis.
Determination offne concentration and speciflc radioactivity
of 3'-phosphoadenosine-5'-phosphosulfate (PAPS) in liver
Concentration and specific radioactivity of PAPS in normal,
galactosamine- and thioacetamide-damaged livers were assayed
by the fluorimetric procedure ofPing Wong & Yeo (31) modified
slightly s previously reported (28). For this purposc an aliquot
of the [35SHabeled liver was pulverized in liquid nitrogcn from
which PAP[3SS1 was extracted with Chloroform. In the presencc
of a dog liver 178,000 £ supernatant the PAPS-bound (3sSJsulfatc
is transfcred quantitatively to harmol. Labeled harmol sulfate was
separated from harmol by thin-layer chromatography and quantit-
ated s reported (28).
Measurement ofthe incorporation of L-[*\l]leucine into protein of
liver slices
Slices from normal and injured livers were incubated for 3 h at
37 °C in Dulbeccos medium containing 0.19 MBq of L-[4,5-3H]-
leucine. At the end of incubation the slices were quickly washed
in ice-cold buffer, boiled for 3 min, dried, and homogenized in
2 ml of destilled water from which an aliquot was taken for the
determination of protein (30). 100 μΐ portions of the homogenate
were spotted ori Whatman 3 MM filter paper disks and sequenti-
ally extracted according to the technique ofMans & Novelli
(32). The incorporation of [3H]leucine is refered to the protein
content of the slice.
Cottecti n ofblood and determination of serum enzyme
activities
Blood was aspirated from the V. cava inf. of the anaesthetized rat
and nonhaemolytic serum prepared. The activities of alanine
aminotransferase (EC 2.6.1.2) (33), aspartate aminotransferase
(EC 2.6.1.1) (34) and leucine arylamidase (EC 3.4.11.) (35)
were measured. The first two were determined in a DuPont
Automatic Clinical Anajyzer, the latter in the Eppendorf enzyme
a tomate ACP 5040. The serum used for incubation studies was
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Fig. 1. Incorporation of [35S]sulfate into hepatic glycosamino-
glycans of rats injured with D-galactosamine.
Rats received between 8.00 and 9.00 a.m. a single dose of
350,mg/kg body weight of £>-galactosamine i.p. and at
various times thereafter 3.7 MBq of f35Sjsulfate 30 min
before sacrification. The livers were removed, defatted,
dried, and subjected to proteoiysis. Total glycosamino-
glycans were isolated and determined by chemical and
enzymatic procedures. At the beginning (day 0) and the
end (day 8) of the study 3 control rats (injected with
saline instead of galactosamine), respectiveiy, were
analysed in a sirnilar way (·---·). Each time point
represents the mean value of 3 separate experiments. the
CV was within 20%.
The incorporation of (35S)sulfate into total glycosamino-
glycans (a), heparan sulfate (b), chondroitin sulfate (c),
and dermatan sulfate (d) is shown.
Results
Synthesis of glycosaminoglyeans in acutely injured rat
liver in vivo
In response to the administration of a single dose of
D-galactosamine (350 mg/kg body weight) to rats the
incorporation of [3S S]sulfate into total liver glycos^
aminoglycans is depressed fapidly and to a great extent
(flg. l a). 30 min after induction of liver injury the incor-
poration is reduced by about 75% reaching the lowest
values after 2 h. Later on the rate of incorporation in-
creases gradually and climaxes between 24 and 48 h.
At this time the labeling of glycosaminoglycans is nearly
twice that found in the respective control livers. 3 to 4
days after application ofthe drug [35S]sulfate ίηΰΟφΟΓ-
ation into glycosaminoglycans is similar to fhat in normal
livers.
J. Clin. Chem. Qin. Biochem. / Vol. 20,1982 / No. 4
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Qualitatively similar biphasic changes were found for
the production of heparan [3SS]sulfate (fig. Ib) but its
Inhibition takes longer and is more severe (nearly com-
plete Inhibition between 0.5 and 4 h) and its Stimula-
tion is less than that of total glycosaminoglycans. This
observation suggests that the production of the other
types of sulfated glycosaminoglycans, i.e. of chondroitin
sulfate and/or dermatan sulfate, is differently affected
in iniured livers. Figure Ic and Id substantiate that the
incorporation of [35S]sulfate into diese types of glycos-
aminoglycans is inhibited only for a short period and to
a small extent when compared to heparan sulfate. In-
stead, their synthesis is greatly, i.e. 3- to 4-fold exagger-
ated S to 24 h after induction of liver damage. At a time
point (4 h) when heparan sulfate production is nearly
completely depressed, the incorporation of [3SS]sulfate
into chondroitin sulfate is 2 times that measured in
control livers.
The duration of the inhibitory phase is dose-dependent;
with 700 mg/kg of Z)-galactosamine the Inhibition of
heparan [35S]sulfate synthesis is extended to 3 days,
that of total glycosaminoglycan production to l day
(not shown). This; again, indicates a strong Stimulation
of the formation of the remaining types of glycosamino-
glycans (chondroitin sulfate, dermatan sulfate) between
1 and 3 days after onset of injury.
The specific radioactivity of liver 3'-phosphoadenosine-
5'-phosphosulfate (PAPS) does not change significantly
in D-galactosamine-injured rat liver, although its concen-
tration in the tissue was found to be reduced by 50%
2 days after initiation of liver damage (tab. 1). Thus, the
changes in the rates of incorporation of [3S S] sulfate
into glycosaminoglycans observed in injured liver seem
to be a true reflection of the biosynthesis of these com-
plex glycoconjugates.
Acute thioacetamide-induced liver damage (100 mg/kg
body weight), resulted in biphasic changes of total and
specific hepatic glycosaminoglycan synthesis, qualita-
tively very similar to those described for galactosamine
(results not shown). Thus, the changing pattern of
glycosaminoglycan synthesis obviously is not related
to the chemical nature and the mechanism of action of
the hepatotoxic compound.
Synthesis of glycosaminoglycans in slicesfrom livers
injured in vivo with D-galactosamine or thioacetamide
The time-dependent changes of the synthesis pattern of
sulfated glycosaminoglycans were studied in more detail
in slices derived from in vivo preinjured livers, thus
eliminating in pari possible influences of extrahepatic
factor^s. In accordance with the in vivo results (fig. 1)
slices from galactosamine-damaged liver (350 mg/kg
body weight) show a strong impairment of their glycos-
aminoglycan synthesis between 0.5 and 6 h after onset
Tab. l. Conccntration and specific radioactivity of 3'-phospho-
adcnosine-5'-phosphosulfate in rat liver following
administration of Z)-galactosaminc.
Rats were injected with 700 nig/kg body weight of D-
galactosamine and received, at the times indicated,
30 min before sacrification, 3.7 MBq of [35S]sulfate.
Portions of the liver were frozen in liquid nitrogen,
weighed and applied tö fluorimetric quantitation and
determination of specific activity of 3'-phosphoadenosine
5'-phosphosulfate. The mean values ± S.p. of 3 to 4 in-



































of injury (fig. 2a). 2 days later the incorporation of
[3SS] sulfate into total glycosaminoglycans is stimülated
by more than 50%. The formation of heparan [35S]suL·
fate exhibits similar time-dependent changes (fig. 2b),
Its depression, however, is more severe than that of total
glycosaminoglycans which is due to an additional
decline in the relative proportion of heparan [3*S]-
sulfate production. Normally this glycosaminoglycan
represents a fraction of about 0.85 of total glycos·:
aminoglycan synthesis but in injured liver its portion is
only about 0.5 (fig. 2b). The loss of heparan sulfate is
"compensated" by a strong relative increase in the pro-
duction of both chondroitin sulfate and dermatan
sulfate (fig. 2c). The incorporation of [3SS] sulfate into
these polysaccharides is only slightly and for a short
period of time reduced, but a 3-fold (dermatan sulfate)
and a nearly 5-fold (chondroitin sulfate) Stimulation
were observed after 24 to 48 h (fig. 2c). Compared with
the time-course of the incorporation of [3H}leucine into
total protein during the first 6 h after gatactosamime-
provoked liver damage, the formation of chondroitin
sulfate and derrriatan sulfate, in contrast to that of
heparan sulfate, seems to be rather independent of pro-
tein synthesis (fig. 2a, inset).
The time-course öf[35S]sulfate iiicorporation into total
glycosaminoglycans in slices prepared from liver in the
state of low (time of injury 4 h) or high (time of injury
48 h) glycosaminoglycan synthesis indicates that the in-
corporation in the latter is linear only up to 6 h, whereas
the förmer (and control liver slices) exhibits linearity at
least up to 8 h of incubation (fig. 3a). It is irnportant to
note that the fraction of heparan [35S]sulfate is not in-
fluenced by the time of incubation, and is only dependent
on the duration of injury, i.e. in the early injured liver
the portion of heparan sulfate is smallest (0.55 instead
of 0.8 in control liver slices, fig. 3b).
J. Ciin. Chem. Qin. Biochem. / Vol. 20, 1982 / No. l
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Fig. 2. The time-depcndence of thc effect of D-galaclosaminc
on thc incorporation of !35S]sulfate into glycosamino-
glycans of liver slices relative to that of untreated (saline
injected) rats.
Rats were injected with a single dose of 350 mg/kg body
weight of jD-galactosaminc and at various times thereafter
anaesthctized. The livers were pcrfused with cold phos-
phate-buffered saline. and exciscd for thc preparation of
slices. The cxplants were incubated for 3 h at 37 °C in
medium containing 0.93 MBq of |3SSjsulfate eithcr in the
absence (a. b o—o) or presence of 0.2 ml serum from
normal (a, b ·—·) and galactosamine (a, b ·—·) treatcd
rats. The incorporation of (35S)sulfate into glycosamino-
glycans of liver slices from galactosamine-treated rats is ex-
pressed äs the proportion of that of control livers incubated
under identical conditions. Each time point is the mean
value of 3 experiments, the CV was within 15%, The rela-
tive incorporation into total glycosaminoglycans (a),
heparan sulfate (b), dermatan sulfate (c, ·—·), and
chondroitin sulfate (c, ·—·). is shown. In (b) heparan
sulfate is expressed also äs fraction of total labeled glycos-
aminoglycans (*—A). The inse-t in (a) reprcsents the incor-
poration of |3H]leucine into total protein of slices from
livers treated for various times with 350 mg/kg body
weight of /)-galactosamine, expressed äs fraction of that
measured in the respective control liver slices.
Total and specific glycosaminoglycan synthesis in slices
from acute thioacetamide-injured livers behaves similarly
to that in galactosamine-damaged tissue (flg. 4). There is
1 2 4
t ( h )
Timeof incubotion
Fig. 3. The effect of galactosaminc-induced livcr injury on the
timc-course of thc incorporation of (3 5Slsulfate into
glycosaminoglycans of liver slices.
Rats were treated with a single dose of 350 mg/kg body
weight of /)-galactosamine; control rats received a similar
volumc of saline (·—·). Thcy were at 4 h (o—o) and
48 ji (·—·) respcctively thereaftcr anaesthctized; their
livers were pcrfused wilh cold buffer and slices prcpared
and incubated at 37 °C for various times in medium con-
taining |35Sjsulfate. The incorporation of the label into
total glycosaminoglycans (a) and the proportion of
heparan |35S]sulfate (b) during incubation is shown.
a lack of Inhibition of dermatan [3sS]sulfate formation
but a strong relative and absolute decrease of heparan
[35S]sulfate production 24 h after application of the
drug. At 2 days the incorporation of [3SS]sulfate into
dermatan sulfate is enhanced 4-fold which is accompanied
by a significant but less pronounced Stimulation on the
synthesis of total glycosaminoglycans and of heparan
sulfate (fig. 4b). It shouid be emphasized that the depres-
sion of liver heparan sulfate synthesis bccurs before the
activities in serum of alanine aminotransferase, aspartate
aminotransferase, and leucine arylamidase increase
(fig. 4b). The relationship between the synthesis of
glycosaminoglycans and incorporation of [3H]leucine
into protein (fig. 4c) is identical to that described for
galactosamine hepatotoxicity.
J. Cün. Chem. Gin. Biochem. / Vol. 20,1982 / No. l
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Effect ofage ofthe rat on galactosamine-induced Inhibi-
tion of liver glycosaminoglycan synthesis
The sensitivity of hepatic glycosaminoglycan formation
to Z)-galactosamine was tested in relation to the age of
the rat. No significant differences were found in the
Fig. 4. The time-dependence of the effect of thioacetamide on
the synthesis of glycosaminogiycans and proteins in liver
slices and on the enzyme activities in serum.
Rats were treated with a single dose of 100 mg/kg body
weight of thioacetamide or a similar volume of saline
(coritrol rats) and at various times thereafter anaesthet-
ized, their livers were perfused with cold buffer and slices
prepared. Inoibation of the explants was for 3 h in the
presence of 0.93 MBq of [3>s S] sulfate. The incorporation
of the isotope into total glycosaminoglycans (b, ·—·),
heparan sulfate (b, o—o),,and dermatan sulfate (b,
•—·) was measured.
The incorporation; of [3H]leueine into the proteins of
thioacetarniderinjuied liver slices expressed äs fraction of
that measured in control rat liver explants is shown in (c).
(a) represents the catalytic conceritratipns of aspartate
aminotransferase (·—·), alanine aminotransferase
(o—o), and leucine arylamidase (·—·) in serum.
dose-dependent Inhibition of the synthesis of total
glycosaminoglycans and of heparan sulfate in liver slices
of 33 moriths and 3.5 months old rats. 50% imhibition is
reached at a dose of about 80 mg/kg of D-galaotösamine.
Moreover, the relative portion of hepäran [35S]sulfate
declined similarly for both age gfoups, from about 0.75
to 0.45—0.55. This implies a concomitant increase in
the fraction of galactpsamine-containing sulfäted glycosr
aminoglycans. Young rats with elevated activities of
alanine aminotransferase in their serum show a sorne-
what stronger inhibition of [?5S]sulfate incorporation
into glycosaminoglycans than those having (still) normal
serum enzyme activities.
Effect of serum from normal and injured rats on the
synthesis of glycosaminoglycans in slices from normal
and injured liver
To define possible humoral regulators of hepatic glycos-
aminoglycan synthesis, slices from normal and diseased
liver were iiicubated in the presence or absence öf serum
from normal and injured rats. Results surnmärized in
table 2 indicate that the incorpojration of [35S]sulfate
Tab. 2. The effect of serum from galactosamine-treated and untreated (control) rats on the synthesis of total glycosaminoglycans and
heparan sulfate in süces from untreated (control) and galactosamine-injured livers.
Rats received 350 mg/kg body weight of D-galactosamine i.p. or a similar volume of 0.154 moi/1 of NaCl i.p. and were sacrXfied
at various times thcreaftcr. Blood was aspirated from the V. cava inf. of the anaesthetized (pentobarbital) animals and the liver per-
fused through the V. porta with ice-cold phosphate buffered saline. Slices from livers were prepared and incubated for 3 h in
2.8 ml ofDulbeccos medium containing 0.93 MBq of [3SSjsulfate in the absence or presence of 0.2 ml of the respective
serum. The incorporation of [3sS]sulfate into glycosaminoglycans is refered to the protein eoritent ofthe liver slice. The
values are the mean of triplicate experiments, the CV was within 12%. The synthesis of heparan sulfate äs a fraction of total
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into glycosaminoglycans of normal liver slices is not
affected by serum from either normal rats or animals
injured for various times withß-galactosamine. Both the
fraction and the total amount of heparan sulfate synthesi-
zed are also unsusceptive to serum. The biphasic modu-
lation of formation of total glycosaminoglycans in slices
from livers injured for various times with Z?-galactosamine
is not significantly influenced by serum from either
normal or injured rats, which is also true for the synthesis
of heparan sulfate, chondroitin sulfate, and dermatan
sulfate (tab. 2). Thus, neither the inhibitory nor the
stimulatory phase of liver glycosaminoglycan production
seems to be mediated by factor(s) residing in the serum
(see also fig. 2).
Action of p-nitrophenyl-fl-D-xylopyranoside on galactos-
amine-induced Inhibition of [3SS]sulfate incorporation
into total liver glycosaminoglycans
From the results described in figure 2 and 4 it can be
deduced that the Inhibition of heparan sulfate synthesis
miglit be due to a depression of the production of the core
protein moiety of the proteoglycan. Consequently, the
introduction of an artificial polysaccharide chain accep-
tor molecule into the cells, e.g./?-nitrophenyl-0.D-xylo-
side, should partially overcome galactosamine-induced
Inhibition of glycosaminoglycan synthesis. It was found
(tab. 3) that in the presence-of l mmol/1 p-nitrophenyl-
ß-£)-xyloside the formation of total glycosaminoglycans
and of heparan sulfate is reduced to 0.70 of that
measured in slices incubated in the absence of this com-
pound. Under conditions of nearly complete Inhibition
of total glycosaminoglycan synthesis (0.5 mmol/1 puro-
mycin) p-nitrophenyl-0-Z)-xyloside is able to increase
[3SS]sulfate incorpoiation about 2.5 fold. However, the
Inhibition of heparan sulfate production induced by
l mmol/1 of £>-galactosamine (0.24 of control) is not
partially reversed by p-nitrophenyl-|3-Z)-xyloside; instead,
a further slight decüne, similar to that measured in un-
treäted liver slices, was found (tab. 3). Thus, the results
do not support the view that diminished core protein
synthesis is the only mechanism of action of £)-galactos-
amine on hepatic glycqsajninoglycan synthesis.
Effects of diethyldithiocäfbafnate and of(+)cianidanol~3
on the Inhibition of glycosaminoglycan synthesis in
galactosamine-injured liver
Pretreatment of rats with a single dose of diethyldithio-
carbamate (300 mg/kg bpdy weight) results in a partial
reversibüity of the Inhibition of [35S].sulfate incorpora-
tion into total liver glycosaminoglycans produced by
D-galactosamine (tab. 4). In addition, the "hepato-
protective" coinpound elevates the diminished fraction
of heparan [35 S] sulfate in diseased liver from 0.52 to
0.69. Thus, heparan sulfate synthesis in acutely,/*·
galactosamine-damaged livers is increased over 6-fold
Tab. 3. The effect of p-nitrophenyl-0-jD-xylopyranoside on the
puromycin or D-galaetosamine-induced Inhibition of
[3S S l sulfate incorporation into liver glycosaminoglycans
and heparan sulfate. Slices were prepared from untreated
rat livers and incubated in medium supplemented with
0.93 MBq of [35SJsulfate either in the absence or pre-
serice of the additions given in the table. The final con-
centrations are listed in parenthescs. Sincc p-nitrophenyl-
/3-D-xyloside was dissolved in 0.5 mol/l dimethylsulfoxide
an appropriate volume of this solvent was added to the in-
cubations without p-nitrophenyl-/3-D-xyloside. Under
these conditions dimethylsulfoxide did not affect the in-
corporation. The data are from one representative ex-




















































by application of diethyldithiocarbamate 45 min prior
to injection of the toxic drug. It should be noted, that
the protective compound reduced, in normal liver, the
production of labeled glycosaminoglycans, without
affecting significantly the relative proportion of heparan
[35S]sulfate (tab. 4). The flavonoid (+)cianidanol-3
partially rescues glycosaminoglycan synthesis from
Inhibition by £>-galactosamine (tab. 4); its effect, how-
ever, is dependent on the action of Z)-galactosamine.
If total glycosaminoglycan production is more severely
inhibited the protective capacity of the flavonoid is
more pronounced and equals that of diethyldithio-
carbamate (not shown).
Discussion
The results presented in this study indicate clearly
biphasic temporal changes in the incorporation of [35S]-
sulfate into various types of liver glycosaminoglycans.
The rate of isotope incorporation probably equals the
rate of carbohydrate chain synthesis since there was no
significant change in injured liver of the specific radio-
activity of the immediate precursor of glycosamino-
glycan sulfation, S'-phosphoadenosine^'-phosphosulfate,
and it has not been shown so far, that sulfate groups of
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Tab. 4. The cftcct of dictliyldithiocarbamatc and of (+)cianid-
anol-3, rospcctivcly, on the galactosamine-induced Inhibi-
tion of glycosaminoglycan synthesis in livcr.
Rats were injccted in vivo witli 700 mg/kg body wcight
of Z)-galactosaminc (dicthyldithiocarbamate experiment)
or 450 mg/kg body weight (cianidanol experiment), or a
similar volume of saline instead of galactosamine (controi
rats). Diethylctitliiocarbamatc (300 mg/kg body weight)
was administered 45 min bcfore the application of
galactosamine. 2 h after injection of galactosamine the
rats were sacrified. (+) Cianidanol-3 (a Suspension of 250
mg/kg body weight in saline) was applied iiitraperitone-
ally 48 h, 24 h. and 3 h beforc injection of D-galactos-
amine into the rats. 3 h after administration of galactos-
amine the animals were decapitated. The liver slices were
prepared and incubatcd with [35Slsulfate äs described.
The values are the mean ± S.D. of 3 experiments. The



















40.7 ± 0.9 (1.0)
24.8 ± 0.1 (0.61)










37.6 ± 7.4 (1.0) 0.80 ± 0.01
35.8 ± 10.4 (0.95) 0.82 ± 0.05
21.4 ± 8.2 (0.56) 0.73 ± 0.04
28.8 ± 10.2 (0.77) 0.78 ± 0.06
liver glycosaminoglycans turn over independently from
the carbohydrate chain backbone. The cyclic modula-
tion of the synthesis of sulfated liver proteoglycans in
response to acute injury obviously is qualitatively
independent of the type and mechanism of action of the
noxious agent, which is true at least for ß-galactosamine
and thioacetamide, but likely also for others (e.g. carbon
tetrachloride, dimethylnitrosamine). Thus, the scheme
presented in figure 5 can probably be generalized for a
variety of acute, toxic liver injuries.
The Inhibition of the synthesis of proteoheparan sulfate
observed in the first phase (fig. 5) might play a pivotal
role in the multistep process of liver cell damage (36) or,
in the Initiation of cell division following injury (37).
Both assumptions arise from the previously discussed
(28) and above briefly mentioned physiological functions
of pericellular proteoheparan sulfate (6, 9-12). In addi-
tion to the key role of changes of the plasmalemma in
the pathogenesis of toxic liver injury (38-41) structural
alterations of the glycocalyx may have importance for
Cell injury-*-! -Reactive fibroproliferation
("fibrogenesis")
Fig. 5. Schematic presentation of the biphasic changes .of prö-
teoglycan synthesis in acutely injured liver, The under-
lying experimental results are giveii in this study.
the loss of the coordtnate exchange of metäbolites and
ions across the cellular barrier which is an early sign of
cellulaf damage.
Under the protective effects of diethyldithiOcarbamate
(42) and of the natural flavonoid (*)cianidanol-3
(43-45) on the development of galactosainine-hepar
titis, a less pronoünced Inhibition of proteogiycan
synthesis was observed. Clearly, the experiments do
not decide whether this resuit is ä consequence of less
severe hepatic damage or vice versa.
As already mentioned depletion of cell surface proteo-
heparan sulfate might trigger the proliferation of liver
cells probably by facilitäting the influx of cell-surface,
membrane associäted Ca2+ into the cytosol (46). A
transient increase in cytosolic free Ca1""1" appears to be
required for enhanced proliferative tendency of normal
and transformed cells (47). Thüs, changes in the compo-
sition of sulfated glycosaminoglycans result in differ-
ences in the metal ion bindijig/release characteristics and
by this might affect the intraeellular availability of peri-
cellular Ca?+ (48). In accordance with this assumption
we found recently deminished synthesis of proteoheparan
sulfate in regenerating rat liver (49). UndOubtedly, more
detailed studies on the cell coat of isoiated membränes
from preinjured liver cells are required to solve these
Problems.
The biochemical mechanisms uriderlying the Inhibition of
synthesis of proteoheparän sulfate and to some degree of
chondroitin sulfate and deimatan sulfate are not eleaf.
From previoüs results (28) it was assumed that dimin-
ished eore protein synthesis öf proteoheparan sulfate
might be crucial, ä Suggestion, which is indirectly
supported here by showing the parällelism of ijgJübited
proteogiycan and general protein synthesis in early stäges
of liver injury. However, we failed to counteract galactos-
amine-inoduced iriMbition of heparan sulfate synthesis
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withp-nitrophenyl-j3-jD-xyloside, an attificial acceptor of
the polysaccharide chains (50, 51), whereas in puro-
mycin-treated slices a slight improvement was achieved.
The latter finding confirms previous results which show
partial restoration of hepatocellular heparan sulfate
synthesis by p-nitrophenyl-j3-/)-xyloside in the absence
of protein synthesis (52). If technical reasons for this
failure are excluded, one might assurne that proteo-
glycan synthesis in galactosamine-damaged liver is
impaired (also) at later biosynthetic Steps, e.g. at the
level of chain initiation and/or elongation.
The stimulated synthesis of proteoglycans in later
stages of acute injury ("overshoot" phenomenon of the
second phase in fig. 5) deserves special interest since it
may represent initial biochemical features of a process
leading to active accumulation of glycosaminoglycans
during long-term injury (27). It is of importance that the
synthesis of chondroitin sulfate and dermatan sulfate,
which are the preponderant types of sulfated glycos-
aminoglycans in fibrotic liver tissue (2,53), is mostly ex-
aggerated. The cellular source of chondroitin sulfate and
dermatan sulfate synthesis needs to be clarified before
any conclusive studies on the molecular mechanisms of
disease-associated Stimulation can be made. Since the
hepatocyte synthesizes nearly exclusively chondroitin
ABC-lyase-resistant glycosaminoglycans (6,9, 54) the
biosynthetic capacity of non-parenchymal liver cells
(mainly sinusoidal lining cells) and of infiltrated in- .
flammatory cells, e.g. or polymorphonuclear leuco-
cytes and monocytes (55) has to be analysed.
A great variety of metabolic processes in the liver are
controlled by humoral factors of hormonal and non-
hormonal nature. The effect of serum factors on proteo-
glycan synthesis in other Systems than liver, e,g. in
embryonic cartilage, is well documented (56-59).
Amazingly, neither Inhibition and Stimulation of
total hepatic glycosaminoglycan synthesis nor the
pattern of specific types was found to be affected by
serum from normal or from injured rats. Thus glycos-
aminoglycan formation in liver explants in short-term
culture seems to be refractory to the action of serum
mediators. Possible reasons might be the relative short
incubation period, saturating intracellular concentra-
tions of the mediators during the time of incubation,
a rapid inactivation of the serum factors in vitro or,
less likely, an unresponsiveness of liver cells to the
respective serum components. The former reasons
might explain, why, in monolayer cultures of rat hepato-
cytes, heparan sulfate synthesis is strongly reduced in the
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